- Design
- nationwide observational cohort, 27 sites, 3-year follow-up
- Population
- 7,836 patients with stable coronary disease undergoing CT angiography with clinically indicated FFR-CT, 2017-2020
- Primary outcome
- myocardial infarction, cardiovascular death, all-cause death and revascularisation, analysed individually
- Effect
- stenosis-specific FFR-CT ≤0.7 adjusted HR 2.94-3.39 for MI; ≤0.5 adjusted HR 2.92 for cardiovascular death; 1.5% 3-year event rate when normal
Patients having coronary CT angiography with clinically indicated FFR-CT analysis at 27 English sites between 2017 and 2020 were followed for three years — 7,836 patients, median age 63, 37.4% women. Lower FFR-CT values tracked stepwise with worse outcomes across myocardial infarction, cardiovascular death, all-cause death and revascularisation. After adjustment for risk factors and for CAD-RADS stenosis severity, stenosis-specific FFR-CT at or below 0.7 remained associated with infarction (adjusted HR 2.94-3.39), and at or below 0.5 with cardiovascular death (adjusted HR 2.92) and all-cause death (adjusted HR 1.49). The optimal threshold for future events fell at 0.67 rather than the familiar 0.8.
The number worth carrying is the other end. Where stenosis-specific FFR-CT was normal, the three-year rate of infarction or cardiovascular death was 1.5%. That is a reassurance figure you can give a patient in clinic, and it is the part of this study most likely to be used.
Stenosis-specific and distal-vessel measurements disagreed in 36.4% of patients, which is a reminder that FFR-CT is not one number per patient. Where a report gives both, they are answering different questions, and the stenosis-specific value is the one these outcome data attach to. Against that, adding FFR-CT to risk factors and stenosis severity moved the C index by 0.012 — statistically clear in a cohort this size, but a small gain in discrimination, and not an argument for the test where anatomy already answers the question.
- Use the 1.5% three-year event rate to reassure patients with a normal stenosis-specific FFR-CT.
- Read the stenosis-specific value, not the distal one, when using FFR-CT for prognosis.
- Treat 0.67 as the value that flags high risk, while 0.8 remains the diagnostic cutoff.
- Check whether a report gives both measurements before quoting a number to a patient — they disagree in about a third.
- Availability and cost put FFR-CT out of reach in much of Indian practice; the finding does not change how to act on a CT angiogram alone.
Why it matters
A reassuring number after CT angiography is the thing clinics most often lack, and this gives one with a denominator behind it.
Don't overread it
Association, not causation — nobody was randomised to having FFR-CT, and a low value has not been shown to be worth acting on.
The statistics, in plain English
This is an observational cohort, so a low FFR-CT marks a patient at higher risk rather than showing that acting on the number improves anything. The hazard ratio ranges quoted reflect different comparison bands, not uncertainty. The change in C index of 0.012 is the honest measure of what FFR-CT adds once risk factors and stenosis severity are known: real, given P < 0.001 in 7,836 patients, but small.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for cardiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free